CNS Pharmaceuticals
-$0.0454 (-6.39%) Today
+$0.0133 (+2.00%) As of 1:00 AM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CNSP and other ETFs, options, and stocks.
About CNSP
CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12.
CEO
John M. Climaco
Employees
5
Headquarters
Houston, Texas
Founded
2017
CNSP Key Statistics
Market cap
18.58M
Price-Earnings ratio
—
Dividend yield
—
Average volume
431.30K
High today
$0.708
Low today
$0.66
Open price
$0.70
Volume
331.14K
52 Week high
$4.46
52 Week low
$0.66
CNSP Earnings
-$0.18
-$0.12
-$0.06
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Feb 11, After Hours